Heliyon,
Год журнала:
2023,
Номер
9(8), С. e18554 - e18554
Опубликована: Июль 22, 2023
Diabetes
mellitus
(DM)
is
not
associated
with
increased
mortality
in
critically
ill
patients,
a
phenomenon
known
as
the
"diabetes
paradox".
However,
DM
risk
factor
for
patients
COVID-19.
This
study
aims
to
investigate
association
of
and
stress-induced
hyperglycemia
at
intensive
care
unit
(ICU)
this
population.This
retrospective
study.
Electronic
medical
records
from
admitted
March
2020
September
were
reviewed.
Primary
outcome
was
mortality.
Secondary
outcomes
ICU
hospital
stay,
need
mechanical
ventilation
renal
replacement
therapy.187
included.
Overall
43.2%,
higher
(55.7%
vs.
34%;
p
=
0.007),
even
after
adjustment
age,
hypertension,
disease
severity.
When
separated
into
groups,
named
normoglycemia
(without
glycemia
≤140
mg/dL),
>140
(previous
diagnosis
or
HbA1c
≥
6.5%),
rate
25.8%,
37.3%,
55.7%,
respectively
(p
0.021).
Mortality
glycemic
variability.
No
statistical
difference
related
secondary
observed.DM,
hyperglycemia,
variability
severe
COVID-19,
but
did
increase
rates
other
clinical
outcomes.
More
than
npj Digital Medicine,
Год журнала:
2023,
Номер
6(1)
Опубликована: Окт. 25, 2023
Abstract
The
increasing
prevalence
of
type
2
diabetes
mellitus
(T2DM)
and
its
associated
health
complications
highlight
the
need
to
develop
predictive
models
for
early
diagnosis
intervention.
While
many
artificial
intelligence
(AI)
T2DM
risk
prediction
have
emerged,
a
comprehensive
review
their
advancements
challenges
is
currently
lacking.
This
scoping
maps
out
existing
literature
on
AI-based
prediction,
adhering
PRISMA
extension
Scoping
Reviews
guidelines.
A
systematic
search
longitudinal
studies
was
conducted
across
four
databases,
including
PubMed,
Scopus,
IEEE-Xplore,
Google
Scholar.
Forty
that
met
our
inclusion
criteria
were
reviewed.
Classical
machine
learning
(ML)
dominated
these
studies,
with
electronic
records
(EHR)
being
predominant
data
modality,
followed
by
multi-omics,
while
medical
imaging
least
utilized.
Most
employed
unimodal
AI
models,
only
ten
adopting
multimodal
approaches.
Both
showed
promising
results,
latter
superior.
Almost
all
performed
internal
validation,
but
five
external
validation.
utilized
area
under
curve
(AUC)
discrimination
measures.
Notably,
provided
insights
into
calibration
models.
Half
used
interpretability
methods
identify
key
predictors
revealed
Although
minority
highlighted
novel
predictors,
majority
reported
commonly
known
ones.
Our
provides
valuable
current
state
limitations
highlights
development
clinical
integration.
Diabetologia,
Год журнала:
2023,
Номер
67(2), С. 223 - 235
Опубликована: Ноя. 18, 2023
Abstract
The
discourse
amongst
diabetes
specialists
and
academics
regarding
technology
artificial
intelligence
(AI)
typically
centres
around
the
10%
of
people
with
who
have
type
1
diabetes,
focusing
on
glucose
sensors,
insulin
pumps
and,
increasingly,
closed-loop
systems.
This
focus
is
reflected
in
conference
topics,
strategy
documents,
appraisals
funding
streams.
What
often
overlooked
wider
application
data
AI,
as
demonstrated
through
published
literature
emerging
marketplace
products,
that
offers
promising
avenues
for
enhanced
clinical
care,
health-service
efficiency
cost-effectiveness.
review
provides
an
overview
AI
techniques
explores
use
potential
data-driven
systems
a
broad
context,
covering
all
types,
encompassing:
(1)
patient
education
self-management;
(2)
decision
support
predictive
analytics,
including
diagnostic
support,
treatment
screening
advice,
complications
prediction;
(3)
multimodal
data,
such
imaging
or
genetic
data.
perspective
how
data-
AI-driven
could
transform
care
coming
years
they
be
integrated
into
daily
practice.
We
discuss
evidence
benefits
harms,
consider
existing
barriers
to
scalable
adoption,
challenges
related
availability
exchange,
health
inequality,
clinician
hesitancy
regulation.
Stakeholders,
clinicians,
academics,
commissioners,
policymakers
those
lived
experience,
must
proactively
collaborate
realise
AI-supported
bring,
whilst
mitigating
risk
navigating
along
way.
Graphical
Frontiers in Pharmacology,
Год журнала:
2024,
Номер
15
Опубликована: Апрель 10, 2024
As
the
quality
of
life
improves,
incidence
diabetes
mellitus
and
its
microvascular
complications
(DMC)
continues
to
increase,
posing
a
threat
people's
health
wellbeing.
Given
limitations
existing
treatment,
there
is
an
urgent
need
for
novel
approaches
prevent
treat
DMC.
Autophagy,
pivotal
mechanism
governing
metabolic
regulation
in
organisms,
facilitates
removal
dysfunctional
proteins
organelles,
thereby
sustaining
cellular
homeostasis
energy
generation.
Anomalous
states
pancreatic
β-cells,
podocytes,
Müller
cells,
cardiomyocytes,
Schwann
cells
DMC
are
closely
linked
autophagic
dysregulation.
Natural
products
have
property
being
multi-targeted
can
affect
autophagy
hence
progression
terms
nutrient
perception,
oxidative
stress,
endoplasmic
reticulum
inflammation,
apoptosis.
This
review
consolidates
recent
advancements
understanding
pathogenesis
via
proposes
perspectives
on
treating
by
either
stimulating
or
inhibiting
using
natural
products.
Antioxidants,
Год журнала:
2024,
Номер
13(8), С. 903 - 903
Опубликована: Июль 26, 2024
Oxidative
stress
(OS)
is
involved
in
the
development
of
diabetes,
but
genetic
mechanisms
are
not
completely
understood.
We
integrated
multi-omics
data
order
to
explore
relations
between
OS-related
genes,
diabetes
mellitus,
and
microvascular
complications
using
Mendelian
randomization
colocalization
analysis.
iScience,
Год журнала:
2024,
Номер
27(4), С. 109511 - 109511
Опубликована: Март 15, 2024
Ferroptosis
and
ferritinophagy
play
critical
roles
in
various
disease
contexts.
Herein,
we
observed
that
ferroptosis
were
induced
both
the
brains
of
mice
with
diabetes
mellitus
(DM)
neuronal
cells
after
high
glucose
(HG)
treatment,
as
evidenced
by
decreases
GPX4,
SLC7A11,
ferritin
levels,
but
increases
NCOA4
levels.
Interestingly,
melatonin
administration
ameliorated
damage
inhibiting
BMC Medical Informatics and Decision Making,
Год журнала:
2025,
Номер
25(1)
Опубликована: Март 17, 2025
Abstract
Background
Identification
of
prognostic
factors
for
diabetes
complications
are
crucial.
Glucose
variability
(GV)
and
its
association
with
have
been
studied
extensively
but
the
inclusion
measures
glucose
(GVs)
in
models
is
largely
lacking.
This
study
aims
to
assess
which
GVs
(i.e.,
coefficient
variation
(CV),
standard
deviation
(SD),
time-varying)
better
predicting
diabetic
complications,
including
cardiovascular
disease
(CVD),
retinopathy
(DR),
chronic
kidney
(CKD).
The
model
performance
between
traditional
statistical
(adjusting
covariates)
machine
learning
(ML)
were
compared.
Methods
A
retrospective
cohort
type
2
(T2D)
patients
2010
2019
Ramathibodi
Hospital
was
created.
Complete
case
analyses
used.
Three
using
HbA1c
fasting
plasma
(FPG)
considered
CV,
SD,
time-varying.
Cox
proportional
hazard
regression,
ML
random
survival
forest
(RSF)
left-truncated,
right-censored
(LTRC)
compared
two
different
data
formats
(baseline
longitudinal
datasets).
Adjusted
ratios
95%
confidence
intervals
used
report
three
complications.
Model
evaluated
C-statistics
along
feature
importance
models.
Results
total
40,662
T2D
patients,
mostly
female
(61.7%),
mean
age
57.2
years
included.
After
adjusting
covariates,
HbA1c-CV,
HbA1c-SD,
FPG-CV
FPG-SD
all
associated
CVD,
DR
CKD,
whereas
time-varying
FPG
CKD
only.
CPH
RSF
(C-indices:
0.748–0.758
0.774–0.787)
0.734–0.750
0.724–0.740)
had
modestly
than
CVD
0.703–0.730
0.698–0.727).
Based
on
importance,
GV
ranked
higher
GV,
both
most
important
prediction.
Both
similar
performance.
Conclusions
We
found
that
based
comparable
Thus,
may
be
as
a
potential
monitoring
parameter
when
unavailable
or
less
accessible.